 Bank of New York Mellon Corp boosted its holdings in Cortexyme, Inc. NASDAQ:CRTX by 180.6 during the fourth quarter, according to its most recent Form 13F filing with the Securities Exchange Commission. The fund owned 38,867 shares of the biopharmaceutical companys stock after acquiring an additional 25,014 shares during the period. Bank of New ... 